Stability and validity of memory-based subtypes of schizophrenia

Journal of the International Neuropsychological Society

Volumn 12, Issue 6, 2006, Pages 782-791

  McDermid Vaz, Stepahanie ^a   Heinrichs, R Walter ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b YORK UNIVERSITY   (Canada)

Author keywords

Cognitive; CVLT; Heterogeneity; Longitudinal; Symptoms; Typologies

Indexed keywords

CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAIN CORTEX; CLUSTER ANALYSIS; COGNITION; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; PARSIMONY ANALYSIS; PRIORITY JOURNAL; PSYCHOMETRY; SCHIZOPHRENIA; SCORING SYSTEM; VALIDITY; VERBAL MEMORY; CLASSIFICATION; COGNITIVE DEFECT; COMPARATIVE STUDY; FOLLOW UP; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; REPRODUCIBILITY; STATISTICS; TIME;

ADULT; CLUSTER ANALYSIS; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; TIME FACTORS; VERBAL LEARNING;

EID: 33947226021     PISSN: 13556177     EISSN: 14697661     Source Type: Journal    
DOI: 10.1017/S1355617706060966     Document Type: Article

References (45)

1. Addington, J. & Addington, D. (2000). Neurocognitive and social functioning in schizophrenia: A 2.5-year follow-up study. Schizophrenia Research, 44, 47-56.
2. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.
3. Bergner, M., Bobbitt, R.A., Carter, W.B., & Gilson, B.S. (1981). The Sickness Impact Profile: Development and final revision of a health status measure. Medical Care, 19, 787-805.
4. Buchanan, R.W. & Carpenter, W.T. (1994). Domains of psychopathology: An approach to the reduction of heterogeneity in schizophrenia. Journal of Nervous and Mental Disease, 182, 193-204.
5. Cirillo, M.A. & Seidman, L.J. (2003). Verbal declarative memory dysfunction in schizophrenia: From clinical assessment to genetics and brain mechanisms. Neuropsychology Review, 13, 43-77.
6. Cuesta, M.J., Peralta, V., & Zarzuela, A. (2001). Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: A longitudinal study. Schizophrenia Research, 48, 17-28.
7. Delis, D.C., Kramer, J.H., Kaplan, E., & Ober, B. (1987). The California Verbal Learning Test Manual, Adult Version - Research Edition. New York: The Psychological Corporation.
8. Goldstein, G. (1990). Neuropsychological heterogeneity in schizophrenia: A consideration of abstraction and problem-solving abilities. Archives of Clinical Neuropsychology, 5, 251-264.
9. Goldstein, G. & Zubin, J. (1990). Neuropsychological differences between young and old schizophrenics with and without associated neurological dysfunction. Schizophrenia Research, 3, 117-126.
10. Gottesman, I.I. & Gould, T.D. (2003). The endophenotype concept in psychiatry: Etymology and strategic intentions. American Journal of Psychiatry, 160, 636-645.
11. Green, M.F. (1996). What are the functional consequences of neurocogntive deficits in schizophrenia? American Journal of Psychiatry, 153, 321-330.
12. Green, M.G., Kern, R.S., Braff, D.L., & Mintz, J. (2000). Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the "right stuff"? Schizophrenia Bulletin, 26, 119-136.
13. Haas, G.L. & Sweeney, J.A. (1992). Premorbid and onset features of first-episode schizophrenia. Schizophrenia Bulletin, 18, 373-386.
14. Hallmayer, J.F., Kalaydjieva, L., Badcock, J., Dragovic, M., Howell, S., Michie, P.T., Rock, D., Vile, D., Williams, R., Corder, E.H., Hollingsworth, K., & Jablensky, A. (2005). Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. American Journal of Human Genetics, 77, 468-476.
15. Harvey, P.D. & Keefe, R.S.E. (2001). Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. American Journal of Psychiatry, 158, 176-184.
16. Heaton, R.K. (1981). Wisconsin Card Sorting Test [Manual]. Odessa, FL: Psychological Assessment Resources.
17. Heaton, R.K., Miller, S.W., Taylor, M.J., & Grant, I. (2004). Revised Comprehensive Norms for an Expanded Halstead-Reitan Battery: Neuropsychologically Adjusted Norms for African-American and Caucasian Males. Odessa, FL: Psychological Assessment Resources.
18. Heinrichs, R.W. (2004). Meta-analysis and the science of schizophrenia: Variant evidence or evidence of variants? Neuroscience and Biobehavioral Reviews, 29, 379-394.
19. Heinrichs, R.W. (2005). The primacy of cognition in schizophrenia. American Psychologist, 60, 229-242.
20. Heinrichs, R.W. & Awad, A.G. (1993). Neurocognitive subtypes of chronic schizophrenia. Schizophrenia Research, 9, 49-58.
21. Heinrichs, R.W., Ruttan, L., Zakzanis, K.K., & Case, D. (1997). Parsing schizophrenia with neurocognitive tests: Evidence of stability and validity. Brain and Cognition, 35, 207-224.
22. Heinrichs, R.W. & Zakzanis, K.K. (1998). Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology, 12, 426-445.
23. Hill, S.K., Ragland, J.D., Gur, R.C., & Gur, R.E. (2002). Neuropsychological profiles delineate distinct profiles of schizophrenia, an interaction between memory and executive function, and uneven distribution of clinical subtypes. Journal of Clinical and Experimental Neuropsychology, 24, 765-780.
24. Joober, R., Rouleau, G.A., Lal, S., Dixon, M., O'Driscoll, G., Palmour, R., Annable, L., Bloom, D., Lalonde, P., Labelle, A., & Benkelfat, C. (2002). Neuropsychological impairments in neuroleptic-responder vs.-nonresponder schizophrenic patients and healthy volunteers. Schizophrenia Research, 53, 229-238.
25. Keefe, R.D.E., Silva, S.G., Perkins, D.O., & Lieberman, J.A. (1999). The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis. Schizophrenia Bulletin, 25, 201-222.
26. Lukoff, D., Kiberman, R.P., & Nuechterlein, K.H. (1986). Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophrenia Bulletin, 12, 578-593.
27. McDermid Vaz, S.A. & Heinrichs, R.W. (2002). Schizophrenia and memory impairment: Evidence for a neurocognitive subtype. Psychiatry Research, 113, 93-105.
28. McGrath, J.A., Nestadt, G., Liang, K.Y., Lasseter, V.K., Wolyniec, P.S., Fallin, M.D., Thornquist, M.H., Luke, J.R., & Pulver, A.E. (2004). Five latent factors underlying schizophrenia: Analysis and relationship to illnesses in relatives. Schizophrenia Bulletin, 30, 855-873.
29. Meehl, P.E. (1995). Bookstraps taxometrics: Solving the classification problem in psychopathology. American Psychologist, 50, 266-275.
30. Meltzer, H.Y., Thompson, P.A., Lee, M.A., & Ranjan, R. (1996). Neuropsychological deficits in schizophrenia: Relation to social function and effect of antipsychotic drug treatment. Neuropsychopharmacology, 14, 27-33.
31. Moscovitch, M. (1982). Multiple dissociations of function in amnesia. In L.S. Cermak (Ed.), Human memory and amnesia (pp. 337-370). Hillsdale, NJ: Erlbaum.
32. Norman, M.A., Evans, J.D., Miller, S.W., & Heaton, R.K. (2000). Demographically corrected norms for the California Verbal Learning Test. Journal of Clinical and Experimental Neuropsychology, 22, 80-94.
33. Nuechterlein, K.H., Robbins, T.W., & Einat, H. (2005). Distinguishing separable domains of cognition in human and animal studies: What separations are optimal for targeting interventions? A summary of recommendations from breakout group 2 at the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophrenia Bulletin, 31, 870-874
34. Overall, J.E. & Gorham, D.R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799-812.
35. Paulsen, J.S., Heaton, R.K., Sadek, J.R., Perry, W., Delis, D.C., Braff, D., Kuck, J., Zisook, S., & Jeste, D.V. (1995). The nature of learning and memory impairments in schizophrenia. Journal of the International Neuropsychological Society, 1, 88-99.
36. Purdon, S.E., Jones, B.D.W., Stip, E., Labelle, A., Addington, D., David, S.R., Breier, A., & Tollefson, G.D. (2000). Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. Archives of General Psychiatry, 57, 249-258.
37. Purdon, S.F., Malla, A., Labelle, A., & Lit, W. (2001). Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. Journal of Psychiatry and Neuroscience, 26, 137-149.
38. Purdue Research Foundation. (1948). Examiner manual for the Purdue Pegboard. Chicago: Science Research Associates.
39. Sitskoorn, M.M., Nuyen, J., Appels, M.C.M., van der Wee, N.J.A., & Kahn, R.S. (2002). Release from proactive inhibition in schizophrenia and its potential as a genotypic marker. Journal of Clinical and Experimental Neuropsychology, 24, 67-81.
40. Toulopoulou, T., Morris, R.G., Rabe-Hesketh, S., & Murray, R. (2003). Selectivity of verbal memory deficit in schizophrenic patients and their relatives. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics), 116B, 1-7.
41. Turetsky, B.I., Moberg, P.J., Mozley, L.H., Moelter, S.T., Agrin, R.N., Gur, R.C., & Gur, R.E. (2002). Memory-delineated subtypes of schizophrenia: Relationship to clinical, neuroanatomical, and neurophysiological measures. Neuropsychology, 16, 481-490.
42. Velligan, D.I., Newcomer, J., Pultz, J., Csernansky, J., Hoff, A.L., Mahurin, R., & Miller, A.L. (2002). Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophrenia Research, 53, 239-248.
43. Wechsler, D. (1981). Wechsler Adult Intelligence Scale-Revised. San Antonio, TX: Psychological Corporation.
44. Wickens, D.D. (1970). Encoding categories of words: An empirical approach to meaning. Psychological Review, 77, 1-15.
45. Zakzanis, K.K. (1998). Neuropsychological correlates of positive vs. negative schizophrenic symptomatology. Schizophrenia Research, 29, 227-233.